This comprehensive guide provides an in-depth look at the Breakthrough T1D (Formerly JDRF) Early-Career Faculty Awards, which encompass the Career Development Award (CDA) and the Kellogg Family Early-Career Patient-Oriented Diabetes Research Award.
Breakthrough T1D is dedicated to fostering the development and productivity of the best and brightest independent researchers who will bridge the gap between the bench and the bedside. If you are an early-career faculty member looking to establish yourself in the Type 1 Diabetes (T1D) research space, these mechanisms offer substantial funding to launch your independent laboratory or clinical research program.
Introduction
Transitioning from a fellowship to a fully independent, funded investigator is notoriously one of the most challenging hurdles in an academic medical career. Breakthrough T1D recognizes this "valley of death" in research funding and has established highly competitive, lucrative awards to support rising stars.
The Career Development Award (CDA) is designed to attract qualified and promising scientists early in their faculty careers, giving them the opportunity to establish themselves in areas that reflect Breakthrough T1D's research emphasis areas. This award is flexible, supporting both basic and clinical research topics.
The Kellogg Family Early-Career Patient-Oriented Diabetes Research Award is tailored specifically for clinical researchers. It provides crucial support to investigators who directly interact with human subjects and are pursuing a career in diabetes-related clinical investigation. Both awards are prestigious markers of excellence that provide stable, long-term funding so you can focus on accelerating life-changing breakthroughs for T1D.
Quick Summary Box: Opportunity Overview
| Feature | Details |
|---|---|
| Program Names | Career Development Award & Kellogg Family Patient-Oriented Research Award |
| Host Organization | Breakthrough T1D (Formerly JDRF) |
| Focus Area | Type 1 Diabetes (T1D) research, including Psychosocial and Behavioral Health |
| Funding Amount | Up to $200,000 USD maximum/year |
| Duration | Up to 5 years (Generally not renewable after 5 years) |
| Target Audience | Early-career faculty members (Assistant Professor or equivalent) |
| Location | Domestic & foreign non-profit organizations, universities, hospitals, labs, and eligible federal agencies |
| Letter of Intent (LOI) | Not Required |
Benefits
Securing a Breakthrough T1D early-career faculty award provides a massive boost to a young investigator's laboratory or clinical program. The funding is substantial and versatile.
- Exceptional Financial Support: Both the CDA and the Kellogg Family Award provide up to $200,000 USD per year for up to 5 years.
- Research Allowance Flexibility: Up to $100,000 of the total costs may be requested as a "research allowance". This allowance can be used to hire personnel (such as a research technician), purchase laboratory supplies, acquire necessary equipment, and cover travel costs.
- Travel Funding: Included in the research allowance, awardees can allocate up to $2,000 USD per year for travel to scientific meetings.
- Salary Support: Salary requests are permitted and must simply be consistent with the established salary structure of the applicant's home institution.
- Indirect Costs: Institutions are allowed to claim up to 10% for indirect costs (excluding equipment) out of the total budget.
Eligibility Criteria
Because these awards are meant to establish the next generation of T1D leaders, the eligibility criteria are strictly gated by career stage and institutional commitment.
For the Career Development Award (CDA):
- Career Stage: You must have received your first faculty-level appointment (e.g., Assistant Professor or equivalent) less than 3 years before the submission date.
- Current Position: You must hold this academic faculty-level position at the time of submission at a university, health science center, or comparable institution with strong, well-established research programs.
For the Kellogg Family Patient-Oriented Research Award:
- Career Stage: You must have received your first faculty-level appointment less than 5 years before the submission date.
- Clinical Focus: You must hold an appointment or joint appointment in a subspecialty of clinical medicine within a clinical department, and explicitly conduct human clinical research.
General Requirements for Both:
- Time Commitment: Awardees must devote at least 75% of their professional time and effort to T1D-related research projects during the period of the award.
- Career Flexibility: Breakthrough T1D is highly sensitive to life events. If you have taken a leave of absence (e.g., parenting, childbirth, long-term caregiving, personal health issues) or experienced a COVID-19 related delay that pushes you past the 3-year or 5-year eligibility window, you should contact Breakthrough T1D staff ahead of applying. They aim to be flexible and adjust time frames appropriately.
Eligible Healthcare Professions
These mechanisms are designed for highly trained doctoral-level professionals entering academic independence.
- For the CDA: Applicants must hold an MD, DMD, DVM, DO, PsyD, PhD, or an equivalent degree.
- For the Kellogg Award: Because this is a patient-oriented award, candidates generally must hold an MD, MD-PhD, DO, or PsyD. Non-MD candidates will only be considered in exceptional circumstances if their work is highly likely to contribute significantly to a clinical outcome.
IMG / International Applicant Considerations
International Medical Graduates and researchers based outside the United States are highly encouraged to apply.
- Global Footprint: Breakthrough T1D is a global funding agency with a substantial proportion of its grants awarded outside the United States.
- Institutional Eligibility: Research may be conducted at foreign non-profit organizations, universities, colleges, and hospitals.
- Currency and Payments: All international awards are issued in USD, and all invoices and expenditure reports must be denominated in USD. International payments are made via Wire Transfer.
- Ethical Clearances: International institutions must adhere to robust human subject and animal welfare guidelines. Ethical approval forms submitted in a language other than English must be accompanied by an English cover letter on institutional letterhead, signed by the department head and the research office, verifying the content.
Required Documents
A successful application requires comprehensive documentation demonstrating your scientific vision and your institution's backing.
- Research Plan: A detailed proposal, limited to 12 pages (including figures and tables, but excluding literature cited). It must include Specific Aims, Background and Significance to T1D, Preliminary Studies, and Research Design/Methods.
- Future Career Plans Statement (2 pages): A statement of your career goals, their relevance to T1D research, your timeline for establishing total independence, and how this award will contribute to your success.
- Department Head Statement (Institutional Assurance): A crucial document where your institutional supervisor guarantees an academic commitment to you and your research, verifying that the facilities are adequate and that your career development is supported.
- Three Recommendation References: Confidential letters assessing your scientific abilities and potential, submitted directly by the referees into RMS360.
- Training Plan Statement (Kellogg Award ONLY): Limited to 4 pages. Because the Kellogg award targets clinical researchers who still require mentorship, a sponsor must provide a biographical sketch, a list of previous trainees, and a detailed plan for supervising and guiding the applicant.
Application Process
Applications must be submitted electronically through RMS360, Breakthrough T1D's web-based grant management system.
- Profile Creation: Ensure your RMS360 profile is up to date, including your Biosketch.
- Drafting the Proposal: Access the specific funding opportunity and download the required templates (e.g., Research Plan). Complete these offline in MS Word.
- PDF Conversion: Convert all completed templates into unencrypted, unlocked PDF files. The file size for each attachment should be limited to 3-4 MB.
- Validation: Upload the PDFs to the "Additional Attachments" section. Ensure all mandatory fields, including the Lay Abstract, are complete.
- Institutional Approval: Once you click "Validate and Submit Proposal to RO," your institutional Research Officer (RO) is notified. The RO must review the budget, certify the information, and click "Submit to Breakthrough T1D" before the deadline.
Tips to Increase Your Chances
- Nail the Lay Abstract: Breakthrough T1D requires both a technical and a lay abstract. The lay audience summary must be clear, concise, and broken down into specific categories (Objective, Rationale, Anticipated Outcome, Relevance to T1D). Reviewers and patient advocates read this carefully.
- Prove Institutional Backing: The review committee heavily scrutinizes the Department Head Statement. A generic letter will hurt your chances; the letter must prove your institution is making a tangible, long-term commitment to your career and providing exceptional laboratory/patient facilities.
- Clearly Define Independence: Use your Future Career Plans statement to explicitly outline how much of your time will be protected for research (must be at least 75%) and how this specific grant will elevate you from a junior faculty member to a recognized leader in the field.
- Address the Clinical Translation: Breakthrough T1D places particular importance on research that may be rapidly translated into clinical applications. Ensure your "Relevance to T1D" section is robust.
Common Mistakes to Avoid
- Exceeding Page Limits: Do not try to squeeze in extra information. The Research Plan is strictly capped at 12 pages. Proposals exceeding this limit will be administratively triaged without review.
- Formatting Errors: You must use a 10-point font size and at least 1/2-inch margins. Avoid using text boxes for figures; insert them directly as .jpg or .gif files. Failure to follow formatting rules results in automatic rejection.
- Requesting Unallowable Costs: Do not include requests for general office supplies, administrative assistance, rent, telecommunications, or patent applications. Computers can only be purchased in year one, and indirect costs cannot exceed 10%.
- Last-Minute RO Submissions: Remember that your submission in RMS360 only routes the application to your internal Research Officer. If your RO does not approve and forward it to Breakthrough T1D by 5:00 PM Eastern on the deadline day, it will not be accepted.
Application Timeline
- Submission: Full proposals are submitted directly (no LOI required).
- Scientific Review: Applications undergo rigorous internal and external peer review based on scientific merit, innovation, and relevance to the Breakthrough T1D mission.
- Kellogg Specifics: The Kellogg award involves an initial screening by a panel of distinguished scientists who evaluate the candidate's potential to conduct innovative patient-oriented research before making final recommendations.
- Notification: Final approval is determined by Breakthrough T1D Senior Management or the Board of Directors. Applicants are notified in writing of their status.
Deadline
Deadlines for these awards are tied to specific Requests for Applications (RFAs) published by Breakthrough T1D throughout the year. All applications are strictly due at 5:00 PM Eastern Time on the specified deadline date.
FY27 Training Awards currently ongoing, deadline is on 2nd July, 2026
FAQs
Q: Do I need to submit a Letter of Intent (LOI) for these awards?
A: No, unlike Strategic Research Agreements (SRAs), neither the Career Development Award nor the Kellogg Family Award requires an LOI. You may submit a full application directly.
Q: Will I receive feedback if my application is rejected?
A: Yes, for applications receiving a full review, Breakthrough T1D generally provides written critiques containing the reviewers' comments. If you choose to resubmit in the future, you must include a 2-page introduction addressing these concerns.
Q: Can I apply for the Kellogg Award if I don't have an MD?
A: It is difficult, but possible. In exceptional circumstances, non-MD candidates (like a PsyD or PhD doing behavioral health) will be considered if their work involves human clinical research and is likely to significantly contribute to a clinical outcome.
Q: Does Breakthrough T1D claim ownership of my intellectual property?
A: No. The grantee institution retains title to inventions developed under the award. However, Breakthrough T1D does require a modest revenue share (royalties) capped at a proportion relative to the funded amount if the product is successfully commercialized.
Official Link(s)
To review the most current RFAs, guidelines, and to access the RMS360 application portal, please visit:
Final Thoughts
The transition to an independent investigator is the most vulnerable phase of a medical researcher's career. Breakthrough T1D’s Early-Career Faculty Awards are designed precisely to protect and propel researchers through this phase. By offering up to $1 million over five years, the Career Development Award and the Kellogg Family Award allow you to build a sustainable, innovative program.
If you are an early-career faculty member with a profound dedication to curing, preventing, or treating Type 1 Diabetes, these mechanisms offer the resources you need to turn your hypotheses into life-changing realities. Secure your institutional support, polish your clinical or basic research plan, and take your place as a future leader in T1D research.
Leave a Comments
Login to comment
No comments yet.